AREC — Arecor Therapeutics Share News
0.000.00%
Last trade - 00:00
- £41.81m
- £33.74m
- £2.40m
RCS - Arecor Therapeutics - ARECOR TO HOST KOL WEBINAR
AnnouncementREG - Arecor Therapeutics - ARECOR PRESENTS AT278 PHASE I DATA AT ATTD MEETING
AnnouncementREG - Arecor Therapeutics - ARECOR 2021 ANNUAL REPORT AND NOTICE OF AGM
AnnouncementREG - Arecor Therapeutics - Arecor on Investor Meet Company Platform
AnnouncementREG - Arecor Therapeutics - FINAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021
AnnouncementRCS - Arecor Therapeutics - ARECOR ANNOUNCES ORAL PRESENTATION AT ATTD 2022
AnnouncementREG - Arecor Therapeutics - Notice of Preliminary Results
AnnouncementRCS - Arecor Therapeutics - Arecor wins at CambridgeshireLive Business Awards
AnnouncementREG - Arecor Therapeutics - Arecor Granted Key U.S Patent
AnnouncementREG - Arecor Therapeutics - ARECOR COMMENCES US PHASE I TRIAL OF AT247
AnnouncementREG - Arecor Therapeutics - ARECOR PROVIDES BUSINESS UPDATE
AnnouncementREG - Arecor Therapeutics - Arecor Provides Update on Agreement with Hikma
AnnouncementREG - Arecor Therapeutics - Arecor Collaborates with Global Technology Leader
AnnouncementREG - Arecor Therapeutics - Grant of Options, PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor Granted Key Canadian Patent
AnnouncementREG - Arecor Therapeutics - Holdings in Company
AnnouncementREG - Arecor Therapeutics - Arecor announces formulation study collaboration
AnnouncementREG - Arecor Therapeutics - Exercise of options, PDMR, Total Voting Rights
AnnouncementREG - Arecor Therapeutics - Arecor’s Polysaccharide Vaccine Patent Upheld
Announcement